WO2023148383A1 - Scellement de fistule - Google Patents

Scellement de fistule Download PDF

Info

Publication number
WO2023148383A1
WO2023148383A1 PCT/EP2023/052868 EP2023052868W WO2023148383A1 WO 2023148383 A1 WO2023148383 A1 WO 2023148383A1 EP 2023052868 W EP2023052868 W EP 2023052868W WO 2023148383 A1 WO2023148383 A1 WO 2023148383A1
Authority
WO
WIPO (PCT)
Prior art keywords
filling
approaching
sealant device
sealant
fistula
Prior art date
Application number
PCT/EP2023/052868
Other languages
English (en)
Inventor
Vicente María LORENZO-ZÚÑIGA GARCÍA
Vicente PONS BELTRÁN
Rubén MARTÍN CABEZUELO
Ana VIDAURRE GARAYO
Guillermo VILARIÑO FELTRER
Isabel TORT AUSINA
Original Assignee
Fundación Para La Investigación Del Hospital Universitario Y Politécnico La Fe De La Comunidad Valenciana
Universitat Politècnica De València
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundación Para La Investigación Del Hospital Universitario Y Politécnico La Fe De La Comunidad Valenciana, Universitat Politècnica De València filed Critical Fundación Para La Investigación Del Hospital Universitario Y Politécnico La Fe De La Comunidad Valenciana
Publication of WO2023148383A1 publication Critical patent/WO2023148383A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • A61B2017/00557—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00641—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closing fistulae, e.g. anorectal fistulae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00818—Treatment of the gastro-intestinal system

Definitions

  • the present disclosure generally relates to devices, systems and methods for sealing fistulae, and more specifically, to a sealant device for sealing a cavity of a fistula, systems and methods.
  • a fistula is a medical disorder in which an abnormal cavity is generated.
  • a fistula can also involve an abnormal connection between two hollow spaces of the body such as blood vessels, intestines, or other hollow organs.
  • the fistula is a blind hole connected to a physiologic lumen through a fistulous orifice.
  • the fistula has a tract with two opened ends.
  • fistulae that generate a fistulous cavity can be the gastrointestinal fistulas owing to their location in the digestive tract. More specifically, post-surgical gastrointestinal fistulas or post-surgical fistulas are described.
  • the post-surgical fistulas may be considered as medical complications due to gastrointestinal surgical procedures such as those associated with oncologic or metabolic bariatric surgery. In these surgical procedures anastomoses are usually performed.
  • Post-surgical fistulas may appear as a complication of an anastomosis of a physiologic lumen.
  • the practitioner may join two sections of the physiologic lumen.
  • post-surgical fistula appears in the region of the junction between the lumen sections. The junction may have stitches, making it difficult to close the fistulous orifice.
  • Postsurgical fistulas usually have a cavity or blind hole configuration, i.e., with only one opening to the physiological lumen.
  • Post-surgical fistula of the anastomosis may be a serious medical complication, and even a cause of postoperative mortality in digestive surgery.
  • Upper gastrointestinal surgery may result in postsurgical complications, such as esophagogastric or gastrojejunal anastomosis leak, whose frequency in countries like Spain is 7.3% and 3.6% respectively.
  • Incidence in anastomotic leak in colorectal surgery seems to remain stable over the last years, around 6.6 % for elective surgery and up to 22.2 % for emergency surgery.
  • a series of factors may favor the appearance of the postsurgical fistula of the anastomosis, such as advanced age, malnutrition, comorbidities, tumor stage, and emergency surgery. This complication may imply several imaging and endoscopic studies, long hospital stays, surgical reinterventions, admission in critical care units and may involve a considerable overuse of healthcare resources. Endoscopic management of gastrointestinal fistula may be a standard of care to avoid surgical reintervention.
  • postsurgical fistulas usually have a cavity or blind hole configuration, i.e., with only one opening to the physiological lumen. Therefore, closing techniques related to other types of fistulas with two end openings cannot be applied. Some comments regarding the latter will be set forth.
  • a plug In fistulas with two open ends, for example between two hollow organs of the body, a plug can be placed in at least one of the ends and tensioned from the other open end to fix the plug.
  • the respective walls of the two organs offer adequate support as they are relatively thick. Logically, this technique cannot be applied in a blind orifice, but if it were applied in post-surgical fistulas there would be a risk of increasing the size of the fistular orifice, as the tissue of the physiological lumen may be thinner.
  • presence of mucosal induration in postsurgical fistulas due to proximity to the mechanical surgical suture of the anastomosis may hinder the correct positioning and anchoring of clips; absence of stenosis in the cavity of the postsurgical fistula may facilitate migration of a stent or the like from the fistula; inability or difficulty to access along the digestive tract with specific tools such as an overtube to implant a vacuum system to reduce the size of the postsurgical fistula; possibility of causing bleeding if vacuum is applied to the postsurgical fistula; there is a risk of the walls of the fistulous cavity sticking together due to the vacuum; practical inability to maneuver an endoscope to perform endoscopic suturing; sealing fluids without containment may migrate through the fistulous orifice of the postsurgical fistula due to lack of adhesiveness; and possibility of interference with the functioning of heart, lung or abdominal organs if sealing material is applied to full obliteration in the mediastinum or peritoneum.
  • a sealant device to seal a cavity of a fistula comprising: a filling element to be filled with a filling fluid to contact, at least, a portion of the cavity in an expanded state; an approaching element having a holding portion to contact at least a part of a wall tissue adjacent to the fistulous orifice, such that the adjacent wall tissue is held in a predefined position relative to a longitudinal axis of the sealant device in the expanded state; a connector to connect the filling element with the approaching element.
  • a device may allow sealing or occluding the cavity of a fistula by virtue of the filling element and an approximation closure at the fistular or fistulous orifice.
  • Closure by approximation of the wall tissue adjacent to the fistular orifice may be achieved despite mucosal indurations.
  • Closure by approximation may be achieved by the action of the holding portion retaining the lumen wall tissue adjacent to or bordering the fistular orifice.
  • the tissue may be retained in a predefined position with respect to the longitudinal axis of the sealant device. This way, the fistulous orifice at least does not become larger and may be occluded while the healing of the fistula.
  • the longitudinal axis may coincide with the connector.
  • the tissue of the wall of the lumen may be approached to the connector.
  • the closure of the fistulous orifice may be performed in the junction area of the anastomosis where stitches may be visible.
  • the holding portion may allow to maintain and even approximate at least a part of the lumen wall tissue in the area adjacent to the fistular orifice.
  • the approximation element may act as a bridging element for these tissues adjacent to the fistular orifice.
  • the predefined position may be related to a position where the edges or boundary of the fistulous orifice defines a predefined span or area.
  • the approaching element When the approaching element is positioned on the walls of the physiologic lumen, the approaching element may tend to reduce the span or area of the fistulous orifice.
  • the predefined position may be related to the size of the fistulous orifice.
  • the approaching element When the approaching element is positioned on the walls of the physiologic lumen, the approaching element may tend to reduce the size of the fistulous orifice.
  • the approaching element may help edges of the fistulous orifice to grow back together.
  • the sealant device may cause the edges of the fistulous orifice to be closer to each other.
  • the filling element may act in combination with the approaching element to enhance the occlusion of the fistulous orifice.
  • the filling element may contact the inner side of the fistulous orifice in an expanded state or condition while the approaching element is retaining or holding the tissue of the lumen in the outer side of the fistulous orifice. This may allow an enhanced approaching of the tissue of the edge of the fistulous orifice to the longitudinal axis of the sealant device.
  • a device for the treatment of fistula cavities may be achieved that may avoid the use of systems intended for fistulas with two end openings.
  • the use of systems that apply tension from opposite openings of the fistula tract to close the orifices may be avoided. This may avoid or at least reduce the risk of fistula enlargement and ischemia or necrosis due to impaired blood supply.
  • the filling element may comprise an inflatable filling balloon.
  • the material with which the fistula is filled may be contained without being released through the fistular orifice.
  • the inclusion of filling material within the cavity may be controlled in a predetermined manner and the full obliteration may be avoided if required.
  • fistulas in the mediastinum, peritoneum or retroperitoneum may be occluded, avoiding or at least reducing the risk of interfering with the heart, lungs or other organs in the area.
  • the filling element may have a permeable cover to release at least a part of the filling fluid in the cavity.
  • bioactive substances or agents e.g., re-epithelializers or antibiotics
  • the latter may be useful in the example of post-surgical fistula, as they are blind and may be septic.
  • the sealant device may achieve a combined effect of mechanical features and bioactive features, namely the closure by approximation and release of the bioactive substance.
  • the bioactive substance may be related to a trophic, antibiotic and/or reparative action.
  • each of the filling element and the approaching element may be filled with different filling fluids from each other.
  • the filling element and the approaching element may release agents with different properties from each other through their outer wall or cover.
  • the fluid released by the approaching balloon may be intended to enhance tissue growth of the physiologic lumen wall.
  • the fluid from the filling balloon may be intended to promote tissue growth where the cavity is defined.
  • the sealant device may be carried by an endoscopic catheter.
  • the endoscopic catheter may be able to reach a fistula in a wall of the small intestine or the like.
  • the fistula may be related to a gastrointestinal fistula. In some examples, the fistula may be a non-vascular fistula.
  • close, closure and the like as used herein may be understood to mean an approximation of the edges of the fistulous orifice, at least to some degree.
  • the expression cavity as used herein may be understood to mean a blind hole.
  • the expression cavity may involve a single fistulous orifice in a wall of the physiological lumen.
  • a bottom of the cavity may be arranged opposite to the fistulous orifice through the path of the cavity.
  • cavity or fistulous cavity are used interchangeably.
  • the fistulous orifice may have an inner side and an outer side.
  • the outer side may face the physiologic lumen and the inner side may face the fistulous cavity.
  • distal as used herein may be understood to mean the area farthest from the practitioner or the area which is to be closer to the fistula in use.
  • a distal end of a part is intended to be closer to a cavity of the fistula in use than a proximal end.
  • proximal as used herein may be understood to mean the area closest to the practitioner or the area which is to be farthest to the fistula in use.
  • a proximal end of a part is intended to be farther to a cavity of the fistula in use than a distal end.
  • Figure 1 schematically illustrates a sealant device having an inflatable approaching element according to an example
  • Figure 2 schematically illustrates the sealant device of Figure 1 with a catheter according to an example
  • Figure 3 schematically illustrates a perspective view of the sealant device of Figure 1;
  • Figures 4 - 6 schematically illustrate the sealant device of Figure 2 with a catheter to seal a cavity of a fistula
  • Figures 7 - 9 schematically illustrate a sealant device according to an example with a catheter to seal a cavity of a fistula
  • Figures 10 - 13 schematically illustrate a sealant device according to a further example with a catheter to seal a cavity of a fistula;
  • Figure 14 schematically illustrates a sealant system according to an example
  • Figure 15 schematically illustrates a sealant system according to a further example
  • Figure 16 schematically illustrates some views of the actuation of the sealant device in a cavity of a physiological lumen according to an example
  • Figure 17 is a block diagram of an example of a method of the present disclosure.
  • Figure 1 schematically illustrates a sealant device 100 having an inflatable approaching element 20 according to an example.
  • a sealant device 100 of the present disclosure comprises a filling element 10 connected to an approaching element 20 through a connector 30.
  • sealant device relating to the digestive tract
  • the relation to the digestive tract is not to be understood as limiting, as other uses may be envisaged where abnormal cavities or blind holes are formed in other parts of the anatomy such as respiratory tract, urinary tract and/or gynecological tract.
  • the fistula may be a non-vascular fistula and/or the fistula may be a gastrointestinal fistula.
  • the physiologic lumen may be non-vascular.
  • the sealant device according to the present disclosure may be employed in conjunction with a catheter and an endoscope for the treatment of fistulas of the digestive tract which are remote from a natural orifice, e.g. mouth and anus.
  • a catheter and an endoscope for the treatment of fistulas of the digestive tract which are remote from a natural orifice, e.g. mouth and anus.
  • different numerical references have been used to designate the same elements of the different examples of the sealant device for the sake of clarity.
  • Figures 2 to 3 illustrate the example of the sealant device 100 shown in Figure 1. Particularly, in Figure 2 it is shown together with a catheter 40 that may be used to fill at least the filling element 10.
  • Figure 3 allows the sealant device 100 to be seen in perspective.
  • the filling element 10 is illustrated in an expanded state, i.e., it has been at least partially filled with filling fluid FF. Particular details about filling of the sealant device will be provided later on.
  • the sealant device 100 that comprises the filling element 10 to be filled with a filling fluid FF to contact, at least, a portion of the cavity C in an expanded state.
  • the sealant device 100 comprises an approaching element 20 that has a holding portion 25.
  • the holding portion may be configured to contact at least a part of the wall tissue WT adjacent to the fistulous orifice FO, such that the adjacent wall tissue WT is held in a predefined position relative to the longitudinal axis LA of the sealant device 100 in the expanded state.
  • the device 100 comprises the connector 30 to connect the filling element 10 with the approaching element 20.
  • the approaching element may be able of or configured to reduce in size from a first or predefined size to a size or second size smaller than the first or predefined size, wherein the reduction in size occurs at least relative to the longitudinal axis LA of the sealant device 100, 200, 300.
  • this reduction in size of the approaching element may involve the holding portion 25 also reducing in size and/or moving closer to the longitudinal axis LA.
  • the holding portion 25 comprises a surface with a geometric shape with respect to the longitudinal axis, the geometric shape may reduce in size and approach the longitudinal axis.
  • the holding portion 25 may define a continuous or discontinuous rim, isolated zones or points, etc.
  • the reduction in size of the approaching element 20, 21 , 22 in combination with the approximation to the longitudinal axis LA, may help reduce the size or dimensions of the fistulous orifice FO, as the physiological lumen wall tissue may remain attached to the holding portion 25 during the reduction in size and approximation to the longitudinal axis of the holding portion 25.
  • this reduction in size of the approaching element may be defined or achieved by an inflatable approaching element with filling fluid that may release filling fluid during a predefined period of time.
  • the reduction in size of the approaching element may be defined or achieved by releasing material from the approaching element itself when the approaching element is formed of at least one bioresorbable material, i.e. when the approaching element comes in contact with the physiological lumen it begins to release material from its structure.
  • the approaching element may be formed of at least one material having elastic properties.
  • a stressed or stretched state of the approaching element may be defined when part of its contour or periphery is relatively and radially away from the longitudinal axis, and a resting state in which the contour or periphery is closer to the longitudinal axis.
  • the holding portion may be placed on the tissue surrounding the fistulous orifice in a stretched state, and the approaching element may tend to close the fistulous orifice.
  • the approaching element may be formed by a combination of at least two materials with different degradation ratios, wherein a second element having a slower degradation ratio than a first element.
  • the second element may have elastic or flexible properties, such that as the first element degrades and reduces its presence in the structure of the approaching element, the second element begins to exert some degree of tension on the wall of the physiological lumen adjacent to the fistulous orifice.
  • the sealant device 100 may comprise an approaching inlet 24 arranged on the approaching element 20, wherein the approaching inlet 24 may be in fluid communication with the filling element 10.
  • the latter can be seen in Figure 2.
  • the approaching inlet 24 may be a kind of port suitable for receiving a catheter 40 or the like to fill the filling element 10.
  • the feature of the approaching inlet 24 has been depicted with reference to Figure 1.
  • the approaching inlet 24 may be present in other examples of the sealant device described in the present disclosure, although not depicted in the figures.
  • the filling element 10 may comprise an inflatable filling balloon.
  • This filling balloon may be a distal balloon.
  • the inflatable filling balloon may be formed, at least, by a cover or the like.
  • the cover may have a bag-like configuration.
  • the interior 50 of the filling balloon may be in fluid communication with the approaching inlet 24.
  • the sealant device 100 may comprise a filling duct 32 to fluidly communicate the approaching inlet 24 to the filling element 10, wherein at least a part of the filling duct 32 may be disposed along the connector 30.
  • the connector 30 may have the filling duct 32 configured to conduct the filling fluid FF or to receive a catheter 40 or the like.
  • the filling duct 32 may be pre-formed during manufacturing.
  • filling duct 32 has been depicted with reference to Figure 1. However, the filling duct 32 may be present in other examples of the sealant device described in the present disclosure, although not depicted in other figures.
  • the approaching element 20 may comprise an inflatable approaching balloon.
  • This filling balloon may a proximal balloon.
  • the inflatable approaching balloon may be formed, at least, by a cover or the like.
  • the cover may have a baglike configuration.
  • the interior 60 of the approaching balloon 20 may be in fluid communication with the approaching inlet 24.
  • the filling element 10 and/or the approaching element 20 is filled via the catheter through the approaching inlet 24, this is not an exclusive example.
  • the filling element 10 and/or the approaching element 20 may be filled via a needle (not illustrated) passing through the outer sheath.
  • the approaching element 20 may have a closing portion 26 to face, at least partially, the physiologic lumen PL.
  • the approaching inlet 24 may be arranged on the closing portion 26 or any other location in the approaching element 20.
  • Figures 4 - 6 schematically illustrate the sealant device 100 of Figure 2 with a catheter 40 to seal a cavity C of a fistula.
  • Figure 4 depicts the sealant device 100 being introduced into the fistula cavity C through the fistulous orifice FO.
  • the catheter 40 may be used as depicted.
  • the sealant device 100 presents a retracted/compressed state or configuration in order to be able to move inside the endoscope.
  • the filling element 10 is in an expanded state due to being filled with filling fluid FF.
  • the expanded filling element 10 contacts the inner side of the fistulous orifice FO.
  • Arrows in the attached Figures indicate the filling fluid FF releasing from the sealant device.
  • the catheter 40 may have a catheter outlet 41 to at least partially fill the sealant device 100.
  • Filling fluid FF may be injected from a proximal end of the endoscope relative to the practitioner.
  • the example sealant device 100 of Figures 4 to 6 does not show the filling duct 32, it may also have a filling duct 32.
  • the end of the catheter where the outlet 41 is located has been moved to the approaching element 20 to fill the interior 60 with filling fluid FF.
  • the filling element 10 may be filled first and then the approaching element 20 in case it is also refillable.
  • Figures 7 - 9 schematically illustrate a sealant device 200 according to an example with a catheter 10 to seal a cavity C of a fistula.
  • the approaching element 21 comprises a disc-like holder.
  • the approaching element 21 may have a body formed as a disc.
  • the approaching element 21 is not filled like the filling element 10.
  • the approaching element 21 may adopt other shapes suitable to contact tissue adjacent to the fistulous orifice.
  • the approaching element 21 When the sealant device 200 of the example of Figure 7 is introduced into the fistula, the approaching element 21 may be compressed and/or folded so that it can be transported through the endoscope. When the approaching element 21 is detached from the catheter 40 it may adopt the deployed configuration of use as shown in Figure 9.
  • Figures 10 - 13 schematically illustrate a sealant device 300 according to a further example with a catheter 40 to seal a cavity C of a fistula.
  • the filling balloon 11 and the approaching balloon 22 are cone-shaped and are arranged opposite to each other, such that the sealant device 300 has a diabolo or hourglass configuration.
  • the filling duct 32 has a non-return valve 31.
  • the approaching inlet 24 comprises a non-return valve 23.
  • Non-return valves 31 and 23 may be arranged in any of the examples disclosed herein. Such valves may serve, among other things, to prevent fluid with which some part of the sealant device is filled from ending up elsewhere. For example, the filling fluid FF may be prevented from ending up in the approaching element 22.
  • the non-return valve 23 may prevent or reduce unwanted leakage from the interior 60 of the approaching element 22.
  • sealant device 100, 200, 300 may be chosen.
  • each of the filling element and the approaching element may be to be filled with different filling fluids FF from each other.
  • the fluid to fill the approaching element may be the filling fluid FF as that one of the filling element.
  • At least one of the filling element and the approaching element may be made from at least two biodegradable materials having different degradation rates.
  • An outer face of at least one the filling element and the approaching element may have a number of pores to release the fluid from the interior 50, 60.
  • at least one of the filling element and the approaching element may comprise a porogenic substance. The porogenic substance may be removed, detached or eliminated in use to define pores in the elements.
  • At least one of an outer face of the filling element and the holding portion may be texturized. This may help to improve the relative attachment of the tissue to the approaching element.
  • At least one of an outer face of the filling element and the holding portion may have a biocompatible adhesive. This may help to improve the relative attachment of the tissue to the approaching element.
  • At least one of the filling element and the approaching element may be made from at least one biodegradable polymer.
  • the biodegradable polymer may be made from at least one of polyester and polyurethane (PUR), or the combination thereof.
  • the polyester may comprise at least one of Poly Glycerol Sebacate (PGS), Polycaprolactone (PCL) and Polylactic Acid (PLA), or the combination thereof.
  • At least one of the filling element 10 and the approaching element 20 comprises a biological component.
  • the biological component may comprise at least one of collagen, gelatin, fibroin, or a combination thereof.
  • At least one of the filling element and the approaching element may be made from at least one biostable elastomer.
  • the connector 30 may be made from a material with flexible properties.
  • the approaching element and the filling element may be brought closer together. This may improve the combined effect of the approaching element and the filling element in relation to the approach closure of the fistulous orifice.
  • the filling fluid FF may have re-epithelializing properties. It may accelerate, enhance or assist the natural process of fistula occlusion.
  • the filling fluid FF may comprise a hydrogel.
  • the filling element 10, 11 may have a permeable cover to release at least a part of the filling fluid FF in the cavity C.
  • the approaching element 20, 21 , 22 may have a permeable cover to release at least a part of the filling fluid FF in the fistulous orifice and/or the tissue surrounding the fistulous orifice.
  • Degradation of the sealant device in use may be in the range of 4-10 weeks, more particularly 6-8 weeks. Gradual reduction of the size of the sealant device may be thus possible to allow the fistula to close at least partially. In the instance where some elements of the sealant device may release filling fluid, this fluid may be released within that time ranges to enhance fistula healing. This may avoid the presence of drains through catheters that exit through natural orifices (mouth I anus).
  • Figures 14 and 15 schematically illustrate sealant systems 500 according to some examples. These figures include the catheter 40 and a portion of the endoscope 70.
  • a sealant system 500 to seal a cavity C of a fistula comprises: a sealant device 100, 200, 300 according to any of herein disclosed examples; and a catheter 40 to apply the sealant device to the fistula.
  • the sealant system 500 may comprise an endoscope 70 having a channel 71 to receive the catheter and the sealant device.
  • the channel 71 may be related to a gastroscope or a colonoscope.
  • the endoscope 70 may have a handle (not illustrated) in a proximal end to the practitioner. There may be Luer-lock connector in the handle.
  • the Luer-lock may comprise infusion or withdrawal syringes to feed the filling fluid FF into the sealant device.
  • Male and female Luer-lock is a standardized system of small-scale fluid fittings used for making leak-free connections between a male fitting and its mating female part on medical and laboratory devices.
  • the catheter 40 When it comes to the digestive tract, the catheter 40 may be introduced into the patient's body through the mouth or anus (not shown) in order to access the digestive tract.
  • the catheter 3 may be advanced to the area of the digestive tract where the fistula is supposed to be located. This area may be referred as a target site.
  • the distal side 43 of the catheter is intended to be the first part to be introduced into the patient's body and is the part of the catheter 40 that is intended to be closest to the fistula to be occluded.
  • the catheter 40 may carry the sealant device 100, 200, 300 in a compressed, retracted, or non-expanded state, see for instance Figures 4 and 7.
  • the catheter may be approximately 200 cm long. This length may be considered relatively long. In one example, the catheter may have a diameter of approximately 2.8 - 3.4 mm. This may be considered a relatively thin diameter.
  • the catheter 40 may be employed through a working channel 71 of the endoscope 70 and moved through the digestive tract to any point in the digestive tract.
  • the sealant device has a width compatible with the diameter of the catheter 40 in a compressed state.
  • the catheter 40 may be made of a suitable material or may have a configuration that allows it to adapt to the shape of the digestive tract. At least the material of the catheter 40 intended to be in contact with the digestive tract may be biocompatible.
  • Figure 16 schematically illustrates some views of the actuation of the sealant device in a cavity of a physiological lumen according to an example.
  • Figure 17 is a block diagram of an example of a method of the present disclosure.
  • a method 400 for sealing a cavity of a fistula is disclosed.
  • the fistula having a bottom and a fistulous orifice on a wall of a physiologic lumen.
  • the method 400 comprises: providing 410 a sealant device 100, 200, 300 according to any of herein disclosed examples in the cavity C using an endoscopic catheter 40.
  • the practitioner may introduce the sealant device via the catheter 40 down or up the digestive tract until the location of the fistula is reached. Once there, he or she may maneuver to insert the distal end 42 with the sealant device into the cavity C.
  • the sealant device may be moved into the cavity in a retracted or unexpanded state; filling 420 the filling element 10, 11 with filling fluid FF to expand the filling element.
  • the practitioner may actuate a syringe arranged on the handle of the endoscope containing the filling fluid. This may cause the filling fluid to flow out of the outlet 41 of the catheter 40 and begin to fill at least one element of the sealant device.
  • the sealing fluid FF As the sealing fluid FF is introduced into the sealant device, it may expand the sealant device; contacting 430, at least, a portion of the cavity with the filling element.
  • the filling element may contact more and more of the cavity surface. In some cases, the filling element may contact the bottom of the cavity or the fistulous orifice. As the filling element fills, it may approach the inner side of the fistulous orifice, i.e. the side opposite the physiological lumen wall.
  • the inner side of the fistulous orifice may be the portion of the cavity that the filling element contacts in an expanded state.
  • the amount of filling fluid introduced may remain inside the filling element and does not spill outside the fistula.
  • the filling element may be filled until a maximum inflation state or point of no return where the filled filling element may be hold to the walls of the fistulous cavity.
  • the practitioner may move the catheter into the lumen of the digestive tract so that the filling element may contact the fistulous orifice on a side opposite the side of physiological lumen. Once the filling element has been filled to the desired volume, the practitioner may disconnect the filling element from the catheter.
  • the connector 30 may be positioned in the fistulous pathway, i.e.
  • the fistulous orifice placing 440 the holding portion of the approaching element onto a part of a wall tissue adjacent to the fistulous orifice, such that the adjacent wall tissue is held in a predefined position relative to a longitudinal axis of the sealant device.
  • the practitioner may maneuver the endoscope to place the approaching element over the fistulous orifice. This way, the fistulous orifice may be occluded.
  • the practitioner may have moved the tissue adjacent to the fistulous orifice toward the longitudinal axis of the sealant device.
  • the adjacent tissue may be placed in a predetermined position to be fixed with the approaching element.
  • the method 400 may comprise approaching part of a wall tissue adjacent to the fistulous orifice with respect to the longitudinal axis of the sealant device, before placing the holding portion.
  • the method 400 may comprise filling the approaching element with filling fluid.
  • the approaching element may be filled, for example, until the approaching element reaches a sufficient size to completely occlude the fistulous orifice.
  • the practitioner may disconnect the approaching element from the catheter.
  • the method 400 may comprise filling each of the filling element and the approaching element with different filling fluids from each other.
  • the physiologic lumen may belong to the digestive tract.
  • the fistula may be a non-vascular fistula.
  • the method 400 may comprise contacting, at least partially, a portion of the fistulous orifice with the filling element in an expanded state.
  • Figure 16 shows an example of the evolution of the sealant device in use at four different time points.
  • a sealant device can be seen that has been separated from the catheter 40.
  • the filled filling element 10 has approached the inner side of the fistulous orifice and the approaching element occludes the fistulous orifice at least on the outer side of the fistulous orifice.
  • the filling fluid FF is seen to be released from the filling element 10.
  • the filling element has not initially contacted the bottom of the fistulous cavity.
  • the size of the fistula and the sealing element have been substantially reduced.
  • the filling element has been releasing filling fluid into the cavity C which has been reduced by the growth of tissue in the patient's body.
  • the physiological lumen free of fistula and sealant device can be seen. Between the first and the last representation, there may be from 8 to 10 weeks.
  • the fistular orifice may have an average diameter of 5 mm. Although this figure may vary.
  • a sealant device to seal a cavity of a fistula, the fistula having a fistulous orifice on a wall of a physiologic lumen comprising: a filling element to be filled with a filling fluid to contact, at least, a portion of the cavity in an expanded state; an approaching element having a holding portion to contact at least a part of a wall tissue adjacent to the fistulous orifice, such that the adjacent wall tissue is held in a predefined position relative to a longitudinal axis of the sealant device in the expanded state; a connector to connect the filling element with the approaching element.
  • Clause 2 The sealant device according to clause 1 , comprising an approaching inlet arranged on the approaching element, wherein the approaching inlet is in fluid communication with the filling element.
  • Clause 3 The sealant device according to any of clauses 1 - 2, wherein the filling element comprises an inflatable filling balloon.
  • Clause 4 The sealant device according to any of clauses 1 - 3, wherein the approaching element comprises an inflatable approaching balloon.
  • Clause 5 The sealant device according to clauses 3 and 4, wherein the filling balloon and the approaching balloon are cone-shaped and are arranged opposite to each other, such that the sealant device has a diabolo or hourglass configuration.
  • Clause 7 The sealant device according to clause 2, comprising a filling duct to fluidly communicate the approaching inlet to the filling element, wherein at least a part of the filling duct is disposed along the connector.
  • Clause 8 The sealant device according to clause 7, wherein the filling duct has a non-return valve.
  • Clause 9 The sealant device according to clause 1, wherein the approaching element comprises a disc-like holder. Clause 10. The sealant device according to any of clauses 1 - 9, wherein at least one of the filling element and the approaching element is made from at least two biodegradable materials having different degradation rates.
  • Clause 11 The sealant device according to any of clauses 3 and 4, wherein an outer face of at least one the filling element and the approaching element has a number of pores to release the filling fluid from the interior.
  • Clause 12 The sealant device according to any of clauses 1 - 11, wherein at least one of an outer face of the filling element and the holding portion is texturized.
  • Clause 13 The sealant device according to any of clauses 1 - 12, wherein at least one of an outer face of the filling element and the holding portion has a biocompatible adhesive.
  • Clause 14 The sealant device according to any of clauses 1 - 13, wherein the fistula is a non-vascular fistula, more particularly the fistula is a gastrointestinal fistula.
  • Clause 15 The sealant device according to any of clauses 1 - 14, wherein the filling element has a permeable cover to release at least a part of the filling fluid in the cavity.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Un dispositif de scellement pour sceller une cavité d'une fistule est fourni. Le dispositif de scellement comprend un élément de remplissage à remplir avec un fluide de remplissage pour entrer en contact avec la cavité dans un état déployé ; un élément d'approche ayant une partie de maintien pour entrer en contact avec un tissu adjacent à l'orifice fistuleux, de telle sorte que le tissu de paroi adjacent est maintenu dans une position prédéfinie ; et un connecteur pour relier l'élément de remplissage à l'élément d'approche. L'invention concerne également un système et un procédé pour sceller la cavité.
PCT/EP2023/052868 2022-02-07 2023-02-06 Scellement de fistule WO2023148383A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22382100.0 2022-02-07
EP22382100 2022-02-07

Publications (1)

Publication Number Publication Date
WO2023148383A1 true WO2023148383A1 (fr) 2023-08-10

Family

ID=80683139

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2023/052868 WO2023148383A1 (fr) 2022-02-07 2023-02-06 Scellement de fistule

Country Status (1)

Country Link
WO (1) WO2023148383A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013762A1 (fr) * 1993-11-17 1995-05-26 El-Dot Ks Dispositif support a implanter
US20070088445A1 (en) * 2005-04-29 2007-04-19 Patel Umesh H Fistula graft with deformable sheet-form material
US20100137999A1 (en) * 2007-03-15 2010-06-03 Bioprotect Led. Soft tissue fixation devices
US20150320408A1 (en) * 2012-12-12 2015-11-12 Georgios Adamidis Balloon Catheter for Treating Enteroatmospheric Fistulae in an Open Abdomen
CN206138142U (zh) * 2016-06-27 2017-05-03 唐维兵 肠造瘘口封堵器
EP2600773B1 (fr) * 2010-08-03 2017-11-01 W.L. Gore & Associates, Inc. Bouchon de tissu

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013762A1 (fr) * 1993-11-17 1995-05-26 El-Dot Ks Dispositif support a implanter
US20070088445A1 (en) * 2005-04-29 2007-04-19 Patel Umesh H Fistula graft with deformable sheet-form material
US20100137999A1 (en) * 2007-03-15 2010-06-03 Bioprotect Led. Soft tissue fixation devices
EP2600773B1 (fr) * 2010-08-03 2017-11-01 W.L. Gore & Associates, Inc. Bouchon de tissu
US20150320408A1 (en) * 2012-12-12 2015-11-12 Georgios Adamidis Balloon Catheter for Treating Enteroatmospheric Fistulae in an Open Abdomen
CN206138142U (zh) * 2016-06-27 2017-05-03 唐维兵 肠造瘘口封堵器

Similar Documents

Publication Publication Date Title
JP6122424B2 (ja) 瘻孔処置用デバイス及びその関連方法
US10470749B2 (en) Fistula grafts and related methods and systems useful for treating gastrointestinal and other fistulae
AU2006320507B2 (en) Devices, systems, and methods for occluding a defect
US9504458B2 (en) Methods and systems for treating complex fistulae
JP2014524780A5 (fr)
US20100249828A1 (en) Inflatable device for enteric fistula treatement
US20080125796A1 (en) Gastrotomy closure device
KR20040030859A (ko) 혈관 봉합 부재 및 전달 장치
RU2077273C1 (ru) Способ наложения кишечного и желудочного свищей
JP2017528199A (ja) 瘻孔治療デバイス及び関連方法
AU2007286657A1 (en) Devices and methods for occluding a fistula
CN107182199B (zh) 用于水密密封开口的生物医学装置
CN104771253B (zh) 一种可降解防返流食管胃吻合支架
CN117643486A (zh) 一种血管闭合器输送系统
WO2023148383A1 (fr) Scellement de fistule
KR20220148222A (ko) 의료 시스템, 디바이스 및 관련 방법
ES2877164T3 (es) Dispositivo médico, en particular para el tratamiento de fístulas
Cwalinski et al. Endoscopic vacuum assisted closure of gastrocutaneous fistula after sleeve gastrectomy combined with fibrin sealant
RU2565096C1 (ru) Способ закрытия свища при несостоятельности культи двенадцатиперстной кишки
Puglisi et al. Laparoscopic repair of morgagni hernia in an adult
RU2344769C1 (ru) Способ наложения заднего толстокишечно-желудочного анастомоза при эзофагопластике
Bhurwal et al. Techniques for Fistula Repair in the GI Tract
JP2024519829A (ja) 標的治療を送達するための管腔並置ステント
IL294784A (en) Install a balloon in it, assisted by an elongated endoscope, for the treatment of abscesses using vacuum, components, kits and methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23702838

Country of ref document: EP

Kind code of ref document: A1